Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Short-Term Debt issuances (2016 - 2025)

Conmed's Short-Term Debt issuances history spans 12 years, with the latest figure at $187.0 million for Q4 2025.

  • For Q4 2025, Short-Term Debt issuances rose 24.67% year-over-year to $187.0 million; the TTM value through Dec 2025 reached $695.4 million, down 7.4%, while the annual FY2025 figure was $695.4 million, 7.4% down from the prior year.
  • Short-Term Debt issuances reached $187.0 million in Q4 2025 per CNMD's latest filing, up from $167.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $254.0 million in Q1 2024 to a low of $62.0 million in Q2 2022.
  • Average Short-Term Debt issuances over 5 years is $146.3 million, with a median of $154.0 million recorded in 2023.
  • Peak YoY movement for Short-Term Debt issuances: surged 154.84% in 2023, then crashed 34.65% in 2025.
  • A 5-year view of Short-Term Debt issuances shows it stood at $90.0 million in 2021, then soared by 58.89% to $143.0 million in 2022, then grew by 25.87% to $180.0 million in 2023, then decreased by 16.67% to $150.0 million in 2024, then increased by 24.67% to $187.0 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Short-Term Debt issuances are $187.0 million (Q4 2025), $167.0 million (Q3 2025), and $175.4 million (Q2 2025).